EXCLUSIVE: Second Sight's Dr. Greenberg Says Company's Technology Has Potential To Treat Glaucoma, Diabetes, Infection, Trauma; Nearly All Forms Of Blindness, Which Could Open Market to 6 Million Patients Globally